Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest news from Datamonitor

September 17, 2007
Research and Development, Sales and Marketing

Cell Therapeutics launches Phase III study for pixantroneCell Therapeutics has launched its phase III clinical trial, known as PIX303, of …

News

NICE approves MSD and Schering-Plough’s Ezetrol

September 14, 2007
Sales and Marketing Inegy, NICE, cv

NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …

News

Novartis launches Cubicin for MRSA

September 14, 2007
Sales and Marketing

Novartis has launched Cubicin – its novel, first-in-class antibiotic – in the UK, in a new indication to treat the …

News

AstraZeneca looks to outflank cholesterol competitors

September 14, 2007
Sales and Marketing

AstraZeneca is to conduct a head-to-head trial of Crestor against rival treatment Vytorin in the hugely competitive cholesterol treatment market.The …

News

BMS outsources safety monitoring to India

September 14, 2007
Sales and Marketing India, safety

A team of 140 people based in Chennai, India, is to help Bristol-Myers Squibb monitor safety and side-effect reports from …

News

Fleishman-Hillard to assist UCB in its Cimzia launch

September 14, 2007
Medical Communications

UCB is preparing its Crohn's disease treatment, Cimzia, for a 2008 launch in Europe.This is the first of a number …

News

Pfizer closes Kent manufacturing base

September 14, 2007
Manufacturing and Production

Pfizer will close its Sandwich, Kent manufacturing plant over the next two years with the loss of 420 jobs.It spells …

News

Resolute wins first global account

September 12, 2007
Medical Communications Resolute

London-based PR agency Resolute has won its first global account since setting up its New York office earlier this year.The …

News

Boehringer bids for oncology presence with lung cancer treatment

September 10, 2007
Sales and Marketing

A novel treatment for lung cancer which could help patients who develop resistance to other drugs is being developed by …

News

UK stem-cell research to benefit from hybrid embryos decision

September 10, 2007
Research and Development stem cell

A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …

News

How can customer insight work for you?

September 10, 2007
Sales and Marketing customers, insight, sales

It should be a very simple equation: if you can understand what motivates clinicians – and all the other prescribing …

Feature

Latest news from Datamonitor

September 10, 2007
Research and Development, Sales and Marketing

Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …

News

New Tsar of Tsars appointed to lead clinical engagement

September 6, 2007

A leading heart surgeon has been appointed to ensure frontline doctors are engaged with health service reform and ensure their …

News

Sanofi manager wins Cranfield scholarship

September 6, 2007
Business Services careers

A scholarship to study for an MBA at the renowned Cranfield School of Management has been won by a pharmaceutical …

News

Merck Serono seeks first-line use for Erbitux

September 6, 2007
Sales and Marketing Erbitux

Merck Serono has seeking a broader licence for its cancer drug Erbitux in Europe to include use as a first-line …

News

AZ opens clinical pharmacology unit in China

September 6, 2007
Research and Development China, em

AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …

News

NICE says yes to asthma treatment Xolair

September 6, 2007
Sales and Marketing Xolair

Xolair, a drug which helps control the most severe cases of allergic asthma, has been approved for use on the …

News

European challenge to restrictions on Sutent prescribing

September 6, 2007

The European Commission has been asked to intervene in a row over a patient's access to kidney cancer drug Sutent, …

News

Generic challenger to Eprex approved

September 6, 2007
Sales and Marketing

The first ever biosimilar version of blockbuster anaemia drug epoetin alfa has been approved in Europe.The drug is marketed by …

News

Look who’s talking now

September 3, 2007
Medical Communications, Sales and Marketing blog, digi pharma, digital pharma, new media, social networking, technology

The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025